Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Alves, Brunna E ^a   Montalvao, Silmara A L ^a   Aranha, Franciso J P ^a   Siegl, Tania F G ^a   Souza, Carmino A ^a   Lorand Metze, Irene ^a   Annichino Bizzacchi, Joyce M ^a   De Paula, Erich V ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INTENSIVE CARE UNIT; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; BLOOD; BLOOD DISEASE; DRUG THERAPY; EVALUATION; FEVER; MIDDLE AGED; NEUTROPENIA; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; DRUG THERAPY; FEMALE; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC;

EID: 77952692518     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-143     Document Type: Article

References (32)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655. 10.1378/chest.101.6.1644, 1303622.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554. 10.1056/NEJMoa022139, 12700374.
3. De Backer D, Donadello K, Favory R. Link between coagulation abnormalities and microcirculatory dysfunction in critically ill patients. Curr Opin Anaesthesiol 2009, 22(2):150-154. 10.1097/ACO.0b013e328328d1a1, 19390244.
4. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348(2):138-150. 10.1056/NEJMra021333, 12519925.
5. Warren HS, Suffredini AF, Eichacker PQ, Munford RS. Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 2002, 347(13):1027-1030. 10.1056/NEJMsb020574, 12324562.
6. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 2004, 8(6):462-468. 10.1186/cc2894, 1065042, 15566617.
7. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006, 203(6):1447-1458. 10.1084/jem.20060375, 2118329, 16702604.
8. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006, 12(2):235-239. 10.1038/nm1351, 16462802.
9. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277(5322):55-60. 10.1126/science.277.5322.55, 9204896.
10. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000, 6(4):460-463. 10.1038/74725, 10742156.
11. Giuliano JS, Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, Zingarelli B, Sukhatme VP, Parikh SM, Wheeler DS. Admission angiopoietin levels in children with septic shock. Shock 2007, 28(6):650-654. 2754128, 18092380.
12. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12(6):R147. 10.1186/cc7130, 2646310, 19025590.
13. Kumpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care 2009, 13(3):R64. 10.1186/cc7866, 2717419, 19416526.
14. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3(3):e46. 10.1371/journal.pmed.0030046, 1334221,1334221, 16417407.
15. Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009, 31(4):348-353. 10.1097/SHK.0b013e318188bd06, 18791490.
16. Herbst C, Naumann F, Kruse EB, Monsef I, Bohlius J, Schulz H, Engert A. Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. Cochrane Database Syst Rev 2009, (1):CD007107.
17. Cherif H, Johansson E, Bjorkholm M, Kalin M. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica 2006, 91(2):215-222.
18. Malik I, Hussain M, Yousuf H. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies. J Infect 2001, 42(2):120-125. 10.1053/jinf.2001.0798, 11531318.
19. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34(6):730-751. 10.1086/339215, 11850858.
20. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22(7):707-710. 10.1007/BF01709751, 8844239.
21. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, et al. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000, 18(16):3038-3051.
22. Uys A, Rapoport BL, Anderson R. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer 2004, 12(8):555-560. 10.1007/s00520-004-0614-5, 15197637.
23. Ellis M. Febrile neutropenia. Ann N Y Acad Sci 2008, 1138:329-350. 10.1196/annals.1414.035, 18837909.
24. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001, 49(3):507-521. 10.1016/S0008-6363(00)00281-9, 11166264.
25. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007, 35(1):199-206. 10.1097/01.CCM.0000251640.77679.D7, 17110873.
26. Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008, 63(10):903-909. 10.1136/thx.2007.087387, 18559364.
27. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005, 111(1):97-105. 10.1161/01.CIR.0000151287.08202.8E, 15611372.
28. Kremer Hovinga JA, Zeerleder S, Kessler P, Romani de Wit T, van Mourik JA, Hack CE, ten Cate H, Reitsma PH, Wuillemin WA, Lammle B. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 2007, 5(11):2284-2290. 10.1111/j.1538-7836.2007.02743.x, 17764538.
29. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002, 30(5 Suppl):S302-312. 10.1097/00003246-200205001-00021, 12004252.
30. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004, 103(11):4150-4156. 10.1182/blood-2003-10-3685, 14976056.
31. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ 2002, 324(7336):539-541. 10.1136/bmj.324.7336.539, 1122451, 11872558.
32. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007, 165(6):710-718. 10.1093/aje/kwk052, 17182981.